PH14888A - 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivative - Google Patents

1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivative

Info

Publication number
PH14888A
PH14888A PH20332A PH20332A PH14888A PH 14888 A PH14888 A PH 14888A PH 20332 A PH20332 A PH 20332A PH 20332 A PH20332 A PH 20332A PH 14888 A PH14888 A PH 14888A
Authority
PH
Philippines
Prior art keywords
quinolin
pyrrolo
tetrahydro
derivative
Prior art date
Application number
PH20332A
Other languages
English (en)
Inventor
Emil Pfenninger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH14888A publication Critical patent/PH14888A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH20332A 1976-10-15 1977-10-14 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivative PH14888A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1308676A CH625521A5 (pt) 1976-10-15 1976-10-15

Publications (1)

Publication Number Publication Date
PH14888A true PH14888A (en) 1982-01-08

Family

ID=4389164

Family Applications (1)

Application Number Title Priority Date Filing Date
PH20332A PH14888A (en) 1976-10-15 1977-10-14 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivative

Country Status (21)

Country Link
US (1) US4235907A (pt)
JP (1) JPS5384994A (pt)
AT (1) AT367421B (pt)
AU (1) AU514226B2 (pt)
BE (1) BE859709A (pt)
CA (1) CA1104136A (pt)
CH (1) CH625521A5 (pt)
DE (1) DE2744772A1 (pt)
DK (1) DK143802C (pt)
ES (1) ES463228A1 (pt)
FI (1) FI61313C (pt)
FR (1) FR2367765A1 (pt)
GB (1) GB1589396A (pt)
IE (1) IE46161B1 (pt)
IL (1) IL53120A (pt)
NL (1) NL7711125A (pt)
NZ (1) NZ185419A (pt)
PH (1) PH14888A (pt)
PT (1) PT67154B (pt)
SE (1) SE7711185L (pt)
ZA (1) ZA776138B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA72611C2 (uk) * 2000-05-17 2005-03-15 Орто-Макнейл Фармацевтикал, Інк. Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази
CN1280292C (zh) 2001-11-14 2006-10-18 奥索-麦克尼尔药品公司 用作磷酸二酯酶抑制剂的被取代的四环吡咯并喹诺酮衍生物
US6800625B2 (en) * 2002-06-19 2004-10-05 Janssen Pharmaceutica N.V. Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
CL2008003573A1 (es) * 2008-11-28 2011-02-18 Univ Talca Metodo de sintesis enantioselectiva de intermediarios de beta-carbolina del tipo pirrolo-quinolonas por hidrogenacion con auxiliares quirales de cloroformiato.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2023514A1 (de) * 1970-05-14 1971-12-02 Badische Anilin- & Soda-Fabrik Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 5,6-gamma-Pyridonderivaten
DE2343549A1 (de) * 1973-08-29 1975-03-13 Thiemann Chem Pharm Fab 4-hydroxychinolinverbindungen und solche verbindungen enthaltende arzneimittel
DE2521544A1 (de) 1975-05-15 1976-12-02 Thomae Gmbh Dr K Neue chinoline

Also Published As

Publication number Publication date
SE7711185L (sv) 1978-04-16
AU514226B2 (en) 1981-01-29
ATA736777A (de) 1981-11-15
FI61313B (fi) 1982-03-31
NZ185419A (en) 1980-08-26
DE2744772A1 (de) 1978-04-20
AT367421B (de) 1982-07-12
ES463228A1 (es) 1979-01-01
BE859709A (fr) 1978-04-13
PT67154B (en) 1979-06-07
FR2367765B1 (pt) 1980-04-18
FI61313C (fi) 1982-07-12
IE46161L (en) 1978-04-15
FR2367765A1 (fr) 1978-05-12
NL7711125A (nl) 1978-04-18
DK143802B (da) 1981-10-12
FI772955A (fi) 1978-04-16
CA1104136A (en) 1981-06-30
DK443477A (da) 1978-04-16
US4235907A (en) 1980-11-25
AU2965977A (en) 1979-04-26
IE46161B1 (en) 1983-03-09
IL53120A (en) 1980-06-30
GB1589396A (en) 1981-05-13
CH625521A5 (pt) 1981-09-30
JPS5384994A (en) 1978-07-26
PT67154A (en) 1977-11-01
ZA776138B (en) 1979-05-30
DK143802C (da) 1982-03-29
IL53120A0 (en) 1977-12-30

Similar Documents

Publication Publication Date Title
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
NZ185292A (en) 3-amino-4-phenyl-6-substitutedamino-1h-pyrazolo(3,4-b)pyridines
EG13910A (en) 1,3,4 substituted parazoline derivatives
GB1524917A (en) Gona-1,9(10)-dienes
GB1542361A (en) 1,4-benzo-dioxan derivatives
NZ183064A (en) 1,3dithiolo (4,5-b) pyrazin-2-ylidenepropane dinitrile-4-oxide
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
GB1556569A (en) 1,5-disubstituted - 2 - pyrrolidones
IL52424A0 (en) 2,6-methano-2h-1-benzoxocins
NZ183846A (en) 1,2,3,3a,4,5-hexahydro-6h-indolo(3,2,1-de) (1,5)-naphthyridines
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
AU2468877A (en) 1,4 -dicyanobytene
PH14888A (en) 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivative
GB1483996A (en) 1,8-naphthyridine derivatives
GB1537635A (en) 15,16-dihydroxyprostaglandins
NZ181317A (en) N-tetrazol-5'-yl-1-oxo-1h-pyrimido(1,2-a)quinolin-2-yl-carboxamides
IL48972A (en) 5-substituted-triazolo (3,4-b)(1,3,4)-cycloalkathiadiazine derivatives
NZ179990A (en) 2-aminomethylene-1,2-dihydor-4h-imidazo (1,2-a) (1,4)-benzodiazepin-1-ones
GB1551409A (en) 3,5-diphenylpyridazine derivatives
AU3178777A (en) Substituted 4,5-dihydroxy-imidazolidine-2-thiones
AU3191777A (en) 1,4-oxathianes
CY1138A (en) 2,3-dihydro-2-oxo-3-benzo(b)thiophenecarboxamides
GB1542832A (en) 1,3-dichloroacetoneoxime derivatives
ZA774088B (en) 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide